XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Curative Options for Hemoglobinopathies: Is MSD the SoC in Thalassemia and Sickle Cell Disease Compared to MUD and Haploidentical HSCT?
Login to view comments.
Click here to Login